Literature DB >> 7529746

CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.

F Kirikae1, T Kirikae, N Qureshi, K Takayama, D C Morrison, M Nakano.   

Abstract

Taxol, a microtubule stabilizer with anticancer activity, mimics the actions of lipopolysaccharide (LPS) on murine macrophages in vitro. Recently, it was shown that taxol-induced macrophage activation was inhibited by the LPS antagonist Rhodobacter sphaeroides diphosphoryl lipid A (RsDPLA). To investigate the mechanisms of taxol-induced macrophage activation, the present study focused on the interaction of LPS, RsDPLA, and taxol in the activation of and binding to macrophages. Taxol alone induced murine C3H/He macrophages to secrete tumor necrosis factor alpha (TNF) and to produce nitric oxide (NO) with kinetics similar to that of LPS. Macrophages from LPS-hyporesponsive C3H/HeJ mice, in contrast, did not yield any detectable TNF and NO production in response to LPS or taxol. RsDPLA inhibited taxol-induced TNF and NO production from C3H/He macrophages in a dose-dependent manner. The inhibition by RsDPLA was specific for LPS and taxol in that RsDPLA did not inhibit heat-killed Listeria monocytogenes- or zymosan-induced TNF production. Polymyxin B blocked the inhibitory effect of RsDPLA on taxol-induced TNF production. The inhibitory activity of RsDPLA appeared to be reversible since macrophages still responded to taxol in inducing TNF production after the RsDPLA was washed out with phosphate-buffered saline prior to the addition of taxol. Taxol-induced TNF production was not inhibited by colchicine, vinblastine, or 10-deacetylbaccatine III. A mutant cell line, J7.DEF3, defective in expression of a CD14 antigen, responded equally well to taxol by producing TNF as did the parent J774.1 cells. This suggested that the activation of macrophages by taxol does not require CD14. Taxol-induced TNF production by the mutant cells was also inhibited by RsDPLA. 125I-labeled LPS and 3H-labeled taxol was reported to bind to J774.1 cells predominantly via CD14 and microtubules, respectively. The binding of 125I-labeled LPS to J7.DEF3 cells was about 30 to 40% of that to J774.1 cells. The binding of 125I-LPS to J774.1 cells was inhibited by unlabeled LPS and RsDPLA but not by taxol. On the other hand, 3H-labeled taxol bound to both J774.1 cells and J7.DEF3 cells in similar time- and dose-dependent manners. The binding of [3H]taxol to these cells was inhibited by taxol but not by LPS or RsDPLA. Although the binding studies failed to examine cross competition for binding to macrophages, a possible explanation of these results is that LPS, RsDPLA, and taxol share the same molecule(s) on murine macrophages for their functional receptor(s), which is neither CD14 nor tubulin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529746      PMCID: PMC173021          DOI: 10.1128/iai.63.2.486-497.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction.

Authors:  T Kirikae; F U Schade; U Zähringer; F Kirikae; H Brade; S Kusumoto; T Kusama; E T Rietschel
Journal:  FEMS Immunol Med Microbiol       Date:  1994-01

2.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

Authors:  J Pugin; C C Schürer-Maly; D Leturcq; A Moriarty; R J Ulevitch; P S Tobias
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages.

Authors:  C Bogdan; A Ding
Journal:  J Leukoc Biol       Date:  1992-07       Impact factor: 4.962

4.  Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages.

Authors:  C L Manthey; M E Brandes; P Y Perera; S N Vogel
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

Review 5.  Lipopolysaccharide antagonists.

Authors:  W A Lynn; D T Golenbock
Journal:  Immunol Today       Date:  1992-07

6.  Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn.

Authors:  I Stefanová; M L Corcoran; E M Horak; L M Wahl; J B Bolen; I D Horak
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

7.  Lipopolysaccharide (LPS) binding to 73-kDa and 38-kDa surface proteins on lymphoreticular cells: preferential inhibition of LPS binding to the former by Rhodopseudomonas sphaeroides lipid A.

Authors:  M G Lei; N Qureshi; D C Morrison
Journal:  Immunol Lett       Date:  1993-06       Impact factor: 3.685

8.  Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells.

Authors:  T Kirikae; F U Schade; F Kirikae; N Qureshi; K Takayama; E T Rietschel
Journal:  FEMS Immunol Med Microbiol       Date:  1994-09

Review 9.  Bacterial endotoxin: molecular relationships of structure to activity and function.

Authors:  E T Rietschel; T Kirikae; F U Schade; U Mamat; G Schmidt; H Loppnow; A J Ulmer; U Zähringer; U Seydel; F Di Padova
Journal:  FASEB J       Date:  1994-02       Impact factor: 5.191

10.  Soluble CD14 participates in the response of cells to lipopolysaccharide.

Authors:  E A Frey; D S Miller; T G Jahr; A Sundan; V Bazil; T Espevik; B B Finlay; S D Wright
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  10 in total

1.  Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide.

Authors:  C A Byrd; W Bornmann; H Erdjument-Bromage; P Tempst; N Pavletich; N Rosen; C F Nathan; A Ding
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli.

Authors:  T Kirikae; F Kirikae; S Saito; K Tominaga; H Tamura; Y Uemura; T Yokochi; M Nakano
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.

Authors:  F Jin; C F Nathan; D Radzioch; A Ding
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia.

Authors:  T Kirikae; M Hirata; H Yamasu; F Kirikae; H Tamura; F Kayama; K Nakatsuka; T Yokochi; M Nakano
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS.

Authors:  T Kirikae; T Nitta; F Kirikae; Y Suda; S Kusumoto; N Qureshi; M Nakano
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Microtubule-disrupting agents inhibit nitric oxide production in murine peritoneal macrophages stimulated with lipopolysaccharide or paclitaxel (Taxol).

Authors:  T Kirikae; F Kirikae; Y Oghiso; M Nakano
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14.

Authors:  M D Cunningham; C Seachord; K Ratcliffe; B Bainbridge; A Aruffo; R P Darveau
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal.

Authors:  L C Denlinger; K A Garis; J A Sommer; A G Guadarrama; R A Proctor; P J Bertics
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

9.  Paclitaxel (Taxol)-induced NF-kappaB translocation in murine macrophages.

Authors:  P Y Perera; N Qureshi; S N Vogel
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  The role of TLR4 in the paclitaxel effects on neuronal growth in vitro.

Authors:  Elena E Ustinova; Galina V Shurin; Dmitriy W Gutkin; Michael R Shurin
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.